LAB FY 2025 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$388M

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$85M-51.1% YoY

Gross Profit

$43M49.9% margin

Operating Income

-$93M-109.3% margin

Net Income

-$75M-87.8% margin

EPS (Diluted)

$-0.20

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$83M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$568M

Total Liabilities

$143M

Stockholders' Equity

$424M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$85M	$174M	-51.1%
Gross Profit	$43M	$84M	-49.5%
Operating Income	-$93M	-$175M	+46.8%
Net Income	-$75M	-$139M	+46.1%